Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
31.31
+0.02 (0.06%)
Nov 9, 2026, 10:33 AM EST - Market open

Pediatrix Medical Group Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,9591,9142,0131,9951,9721,911
Revenue Growth
1.91%-4.92%0.92%1.15%3.18%10.22%
Gross Profit
511.69493.7454.34421.57467.03513.24
Operating Income
237.98231.09183.68157.85200217.74
Net Income
150.09165.39-99.07-60.4166.34130.96
Earnings Per Share
1.831.94-1.19-0.730.781.53
EPS Growth
-4.32%----48.62%-

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
425.84499.72348.51177.74103.06487.11
Total Debt
612634.62662.31701.65717.081,066
Net Cash (Debt)
-186.17-134.89-313.81-523.91-614.02-578.72
Net Cash Growth
------
Net Cash Per Share
-2.27-1.58-3.77-6.37-7.30-6.74

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
226.89271.09206.57137.33166.9476.74
Capital Expenditures
-17.29-18.46-22.02-33.33-29.71-32.25
Free Cash Flow
209.59252.63184.55104137.2344.49
Free Cash Flow Growth
-23.34%36.89%77.46%-24.22%208.47%-74.70%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
26.12%25.80%22.57%21.14%23.68%26.86%
Operating Margin
12.15%12.07%9.13%7.91%10.14%11.39%
Pretax Margin
10.38%11.31%-5.03%-2.42%4.13%7.08%
Profit Margin
7.66%8.64%-4.92%-3.03%3.36%6.85%
FCF Margin
10.70%13.20%9.17%5.21%6.96%2.33%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
17.1410.89--18.3517.71
Forward PE
12.949.928.867.408.2916.25
P/FCF Ratio
11.457.136.017.418.8752.14
PS Ratio
1.230.940.550.390.621.21